MedTrace Logo

A Cross-sectional Study Examining Adipose Tissue in Obstructive Sleep Apnea

NCT03307330 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2026-02-13

No results posted yet for this study

Summary

Studies show that sleep apnea increases the risk of cardiovascular disease and is associated with obesity. However, it is unclear how sleep apnea affects fat tissue. Studies have shown that fat tissue is likely involved in developing cardiovascular disease. The purpose of this study is to see how sleep apnea changes fat tissue.

Conditions

  • Obstructive Sleep Apnea of Adult

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Virend Somers, MD., Ph.D · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-08
Primary Completion
2029-12-31
Completion
2029-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03307330 on ClinicalTrials.gov